Improving Alzheimer's Disease Diagnosis with Artificial Intelligence and Neuropsychological Tests
DOI:
https://doi.org/10.47611/jsrhs.v12i3.4777Keywords:
Alzheimer's Disease, Mild Cognitive Impairment, Dementia, Machine Learning, Artificial Intelligence, NeuropsychologyAbstract
Alzheimer's Disease (AD) is a type of progressive dementia that causes loss of memory and function. It affects over 5.8 million people sixty years of age and older in the United States alone. When an individual has AD, neurodegeneration ultimately leads to severe impairment and eventually death. Throughout the stages of the disease, symptoms can range from mild forgetfulness to loss of motor control and bodily functions. Unfortunately, the disease may go unnoticed during initial stages if not tested for and detected early. Signs of Alzheimer's may accidentally be overlooked by physicians, especially if they are subtle. Artificial intelligence (AI) and machine learning models (ML) can be used to improve the identification process of early signs of AD. Some neuropsychological impairments AD patients suffer from include memory loss, difficulty recalling words or phrases, changes in personality and behavior, and decline in bodily functions that affect day to day life. AI may be able to pick up certain details and data that human perception cannot. If trained with a proper data set, ML models would be helpful to physicians in this area of healthcare. In this systematic review, the different neuropsychological impairments visible in the early stages of AD will be discussed as they relate to ML, deep learning, and AI applications intended to aid the diagnosis of AD.
Downloads
References or Bibliography
Emmady, P. D., School, C., & Tadi, P. (2022). Major Neurocognitive Disorder (Dementia). StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK557444/.
Yiannopoulou, K. G., & Sokratis G. P. (2013). Current and Future Treatments for Alzheimer’s Disease. Therapeutic Advances in Neurological Disorders, 6(1), 19–33. https://doi.org/10.1177/1756285612461679.
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018). Inflammation as a Central Mechanism in Alzheimer’s Disease. Alzheimer’s & Dimentia: Translational Research & Clinical Interventions, 4(1), 575-590. https://doi.org/10.1016/j.trci.2018.06.014.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
Liu, L., Zhao, S., Chen, H., and Wang, A. (2020). A New Machine Learning Method for Identifying Alzheimer’s Disease. Simulation Modelling Practice and Theory, 99. https://doi.org/10.1016/j.simpat.2019.102023.
Luber, S. (2011). Cognitive Science Artificial Intelligence: Simulating the Human Mind to Achieve Goals. In 2011 3rd International Conference on Computer Research and Development, 1, 207–210, https://doi.org/10.1109/ICCRD.2011.5764005.
Mitchell, T. M. (1997). Machine Learning. McGraw-Hill Series in Computer Science.
Kang, M. J., Kim, S. Y., Na, D. K., Kim, B. C., Yang, D. W., Kim, E. J., Na, H. R., Han, H. J., Lee, J., Kim, J. H., Park, K. H., Park, K. W., Han, S., Kim, S. Y., Yoon, S. J., Yoon, B., Seo, S. W., Moon, S. Y., Yang, Y., Youn, Y. C. (2019). Prediction of Cognitive Impairment via Deep Learning Trained with Multi-Center Neuropsychological Test Data. BMC Medical Informatics and Decision Making, 19(231), https://doi.org/10.1186/s12911-019-0974-x.
Shahbaz, M., Ali, S., Guergachi, A., Niazi, A., & Umer, A. (2019). Classification of Alzheimer’s Disease Using Machine Learning Techniques. In Proceedings of the 8th International Conference on Data Science, Technology and Applications, 296–303. https://doi.org/10.5220/0007949902960303.
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-Mental State. A Practical Method for Grading the Cognitive State of Patients for the Clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/10.1016/0022-3956(75)90026-6.
Rey, A. (1964). L’examen clinique en psychologie. 2e éd. Psychologue. Presses universitaires de France.
Pfeffer, R. I., Kurosaki, T. T., Harrah Jr, C. H., Chance, J. M., & Filos, S. (1982). Measurement of Functional Activities in Older Adults in the Community. Journal of Gerontology, 37(3), 323–329, https://doi.org/10.1093/geronj/37.3.323.
Gurevich, P., Stuke, H., Kastrup, A., Stuke, H., & Hildebrandt, H. (2017). Neuropsychological Testing and Machine Learning Distinguish Alzheimer’s Disease from Other Causes for Cognitive Impairment. Frontiers in Aging Neuroscience ,9(114), https://www.frontiersin.org/articles/10.3389/fnagi.2017.00114.
Wechsler, D. (1987). Wechsler memory scale—Revised: Manual. Psychological Corporation.
Beck, A. T. H., and Bailer, M. (1985). BDI: Beck-Depressions-Inventar. Göttingen: Hogrefe.
Gold, C. A., Marchant, N. L., Koutstaal, W., Schacter, D. L., & Budson, A. E. (2007). Conceptual fluency at test shifts recognition response bias in Alzheimer's disease: Implications for increased false recognition. Neuropsychologia, 45(12), 2791-2801. https://doi.org/10.1016/j.neuropsychologia.2007.04.021.
Hildebrandt, H., Haldenwanger, A., & Eling, P. (2009). False recognition helps to distinguish patients with Alzheimer’s disease and amnestic MCI from patients with other kinds of dementia. Dementia and Geriatric Cognitive Disorders, 28(2), 159-167. https://doi.org/10.1159/000235643.
Haldenwanger, A., Eling, P., Kastrup, A., & Hildebrandt, H. (2010). Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer's disease. Journal of Alzheimer's Disease, 22 (3), 971-980.
Rohrer, J. D., Knight, W. D., Warren, J. E., Fox, N. C., Rossor, M. N., & Warren, J. D. (2008). Word-finding difficulty: a clinical analysis of the progressive aphasias. Brain, 131(1), 8-38. https://doi.org/10.1093/brain/awm251
Morris, J. C., Mohs, R. C., and Rogers, H. (1989). Consortium to establish a registry for Alzheimer’s Disease (CERAD) clinical and neuropsychological. Psychopharmacology, 24(4), 641-652.
Battista, P., Salvatore, C., & Castiglioni, I. (2017). Optimizing Neuropsychological Assessments for Cognitive, Behavioral, and Functional Impairment Classification: A Machine Learning Study. Behavioural Neurology, Article e1850909. https://doi.org/10.1155/2017/1850909.
Critchley, M. (1953). The Parietal Lobes. Hafner Publishing Company.
Reitan, R. M. (1958). Validity of the Trail Making Test as an Indicator of Organic Brain Damage. Perceptual and Motor Skills, 8(3), 271–276. https://doi.org/10.2466/pms.1958.8.3.271.
Nelson, H. E., and Willison, J. (1991). National adult reading test (NART). Windsor: NFER-Nelson.
Llano, D. A., Laforet, G., & Devanarayan, V. (2011). Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease. Alzheimer Disease & Associated Disorders, 25(1), 73-84. https://doi.org/10.1097/WAD.0b013e3181f5b8d8.
Yesavage, J. A., & Sheikh, J. I. (1986). 9/Geriatric Depression Scale (GDS). Clinical Gerontologist, 5(1–2), 165–73. https://doi.org/10.1300/J018v05n01_09.
Almubark, I, Chang, L. -C., Nguyen, T., Turner, R. S., & Jiang, X. (2019). Early Detection of Alzheimer’s Disease Using Patient Neuropsychological and Cognitive Data and Machine Learning Techniques. 2019 IEEE International Conference on Big Data (Big Data), 5971–73. https://doi.org/10.1109/BigData47090.2019.9006583.
Bhagya Shree, S. R., and Sheshadri, H. S. (2014). An Initial Investigation in the Diagnosis of Alzheimer’s Disease Using Various Classification Techniques. 2014 IEEE International Conference on Computational Intelligence and Computing Research, 1–5. https://doi.org/10.1109/ICCIC.2014.7238300.
Lee, G. G., Huang, P. -W., Xie, Y. -R., & Pai, M. -C. (2019). Classification of Alzheimer’s Disease, Mild Cognitive Impairment, and Cognitively Normal Based on Neuropsychological Data via Supervised Learning. TENCON 2019 - 2019 IEEE Region 10 Conference (TENCON), 1808–1812. https://doi.org/10.1109/TENCON.2019.8929443.
El-Sappagh, S., Alonso, J. M., Islam, S. M., Sultan, A. M., & Kwak, K. S. (2021). A Multilayer Multimodal Detection and Prediction Model Based on Explainable Artificial Intelligence for Alzheimer’s Disease. Scientific reports,11(1), 1-26. https://doi.org/10.1038/s41598-021-82098-3.
Guo, Z., Ling, Z., & Li, Y. (2019). Detecting Alzheimer’s Disease from Continuous Speech Using Language Models. Journal of Alzheimer’s Disease, 70(4), 1163–1174. https://doi.org/10.3233/JAD-190452.
Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019). Key Challenges for Delivering Clinical Impact with Artificial Intelligence. BMC Medicine, 17, 1-9. https://doi.org/10.1186/s12916-019-1426-2.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Akshita Raghuraman; Emily Avery
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
